一名新冠肺炎患者的心包积液：是渗出液还是漏出液？
Pericardial Fluid in a COVID-19 Patient: Is It Exudate or Transudate?
作者信息
Allam Hassan H, Kinsara Abdulhalim J, Tuaima Tareq, Alfakih Shadwan
机构信息
King Abdullah Medical Complex, Jeddah, Ministry of Health, Jeddah, Saudi Arabia.
Ministry of National Guard-Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
出版信息
Eur J Case Rep Intern Med. 2020 May 12;7(6):001703. doi: 10.12890/2020_001703. eCollection 2020.
BACKGROUND
Very limited information is available on pericardial effusion as a complication of COVID-19 infection. There are no reports regarding pericardial fluid findings in COVID-19 patients.
CASE DESCRIPTION
We describe a 41-year-old woman, with confirmed COVID-19, who presented with a large pericardial effusion. The pericardial fluid was drained. We present the laboratory findings to improve knowledge of this virus.
DISCUSSION
We believe this is the first such reported case. Findings suggested the fluid was exudative, with remarkably high lactate dehydrogenase and albumin levels. We hope our data provide additional insight into the diagnosis and therapeutic options for managing this infection. Laboratory findings of drained pericardial fluid in a patient with COVID-19 are presented.The clinical presentation of pericardial involvement in COVID-19 infection and the role of echocardiography in diagnosis and management are described.
背景
关于心包积液作为新型冠状病毒肺炎（COVID-19）感染并发症的信息非常有限。目前尚无关于COVID-19患者心包积液检查结果的报道。
病例描述
我们描述了一名确诊为COVID-19的41岁女性，她出现了大量心包积液。心包积液已引流。我们展示实验室检查结果以增进对这种病毒的了解。
讨论
我们认为这是首例此类报道病例。检查结果表明积液为渗出液，乳酸脱氢酶和白蛋白水平显著升高。我们希望我们的数据能为该感染的诊断和治疗选择提供更多见解。本文展示了一名COVID-19患者引流心包积液的实验室检查结果。描述了COVID-19感染中心包受累的临床表现以及超声心动图在诊断和管理中的作用。
Zotero 插件